Sarcomas of the aorta are rare tumors with an unknown incidence and wide variety of clinical presentations. These malignant neoplasms are often manifested in an advanced state and with symptoms of nonmalignant vascular disease owing to a delay in diagnosis. We present the case of a 78-year-old man in whom workup was initially performed for a persistently enlarging abdominal aortic aneurysm after endovascular aortic repair but who was subsequently found to have a pleomorphic undifferentiated sarcoma of the aorta. (J Vasc Surg Cases and Innovative Techniques 2019;5:294-7.) Keywords: Angiosarcoma; Endoleak; EVAR; Aneurysm Repair of abdominal aortic aneurysms (AAAs) is primarily performed with an endovascular rather than an open approach because of improved morbidity and faster recovery without inferiority in repair.
Repair of abdominal aortic aneurysms (AAAs) is primarily performed with an endovascular rather than an open approach because of improved morbidity and faster recovery without inferiority in repair. 1, 2 Primary malignant sarcomas of the aorta are often manifested as nonmalignant vascular disease, such as aneurysms, endoleaks after endovascular repair, and embolic phenomena. We present the case of a pleomorphic undifferentiated sarcoma discovered during an attempted open abdominal aorta repair with explantation of an aortic stent graft. The patient's wife provided written consent for publication of this report and images.
CASE REPORT
A 78-year-old man was referred to a tertiary care medical center for an enlarging infrarenal AAA with endoleak after initial (Fig 1) and several liver lesions identified as cysts (Fig 2) . with multiple areas of nodularity (Fig 3) . Intraoperative biopsy specimens were taken of this mass and sent for pathologic examination, which revealed pleomorphic undifferentiated sarcoma. The surgical oncology team was consulted, and a biopsy specimen was taken from one of many liver lesions, revealing sarcoma. With the diagnosis of metastatic sarcoma, the decision was made to abort the operation and to notify the patient of the new diagnosis.
The patient recovered from surgery, and the medical oncology service was consulted; outpatient staging with positron emission tomography/computed tomography and chemotherapy were recommended. The patient declined further treatment, was discharged home on hospice care, and died several months later.
Final pathologic examination revealed high-grade spindle and pleomorphic sarcoma with lymphovascular invasion (Fig 4) and positive CD68 staining (Fig 5) aorta, 27% to 42%; and thoracoabdominal aorta, 12% to 25%. The aortic arch was involved in 26% of cases.
5,6
The malignant neoplasms can arise from the adventitia, media, or intima. Primary intimal lesions are the most common and primarily are manifested with embolic events or aortic obstruction. 3, 5, 7 Tumors arising from the adventitia or media tend to form mural tumors with extravascular growth and aortic wall compromise. 3 Aortic arch sarcomas of intimal origin are uniquely associated with cerebral emboli and early metastasis to the brain. 3 Undifferentiated histology is the most common at 39%, followed by angiosarcomatous at 37%, with leiomyosarcomas and fibrosarcomas significantly less common. 3 The diagnosis of primary aortic sarcoma is difficult because the presenting symptoms are similar to those of nonmalignant vascular disease. With the trend toward endovascular intervention, there is less opportunity for examination of aortic specimens to determine malignant potential. 2 The diagnosis of aortic sarcoma is
commonly made during open aortic repair. [6] [7] [8] Many imaging modalities have been evaluated, including CTA, arteriography, and magnetic resonance angiography (MRA). Unfortunately, there appear to be no specific imaging characteristics on CTA; the most common pathologic changes represent dissection, aneurysm, or intraluminal filling defects. 9 MRA appears to offer the most diagnostic potential, with lobulated heterogeneously enhancing masses involving the aorta being associated with malignant disease. [10] [11] [12] However, it remains difficult to identify the populations who benefit from MRA evaluation; some argue for MRA evaluation in those with uncharacteristic disease (ie, aortic thrombus without aneurysm or aortic dissections without risk factors), those with intraluminal masses, or those with lesions in bone or lung and liver as these are common points of sarcoma metastasis. 12 MRA could also be expanded to those with a refractory endoleak as this may be a manifestation of aortic sarcoma masquerading as an endoleak, as noted in our patient and others in the literature. 5 Treatment of aortic sarcoma remains difficult, with overall 5-year survival at 8% and 50% mortality at 1 year. 2 The most commonly accepted avenue of treatment is en bloc resection of the tumor with bypass grafting, which is believed to offer the greatest possibility of cure. 5, 13 Palliative bypass grafting, endarterectomy, and stenting have been proposed for those with metastatic disease. There is some limited evidence for the use of chemotherapy in the treatment of aortic sarcomas in combination with surgery, but the overall survival outcome remains poor. 6 The factor most prognostic for survivability is that of metastatic disease on diagnosis, which appears to affect nearly 80% of known cases; the most common sites of spread include the lung, bone, skin, and liver. 12, 14, 15 A phenomenon noted in several case reports and murine models is the association of angiosarcoma at sites of aortic Dacron grafts and polytetrafluoroethylene dialysis grafts. [16] [17] [18] [19] The graft can be that of an open replacement or endovascular repair. The patient often presents many months or years after intervention with development of symptoms such as pain and enlarging pseudoaneurysm. Patients often undergo multiple examinations and interventions before an open repair is undertaken whereby the diagnosis is made. 5, 14, 20, 21 The time from graft placement to tumor diagnosis varies (3 months-7 years) but averages 48 months. 3 In the majority of graft-associated aortic sarcoma cases, patients already suffer from metastatic disease and their survival is marginal. As in nongraft-associated aortic sarcomas, MRA may offer higher sensitivity of detection, but this has yet to be formally proven.
CONCLUSIONS
We describe the case of a 78-year-old man diagnosed with metastatic pleomorphic undifferentiated aortic sarcoma at the site of a previously placed Gore Excluder device during attempted explantation for persistent aneurysmal enlargement. Aortic sarcomas are a rare disease with poor outcomes probably related to a delay in diagnosis, allowing disease metastasis. In review of our preoperative imaging, the expanding aortic sac with asymmetric wall morphology and cystic liver lesions were the only findings suggesting a neoplastic process. Recognizing aberrant symptom patterns associated with aortic sarcoma and the use of MRA may allow early diagnosis and improved outcomes. 
